Navigation Links
Coherus anuncia que CHS-0214 (biosimilar etanercept propuesto) supera punto final primario en decisivo estudio clínico farmacocinético
Date:10/28/2013

r costos y ampliar el acceso a los pacientes.  Para información adicional, por favor visite www.coherus.com.

Acerca de Baxter International, Inc.

Baxter International, Inc., a través de sus subsidiarias, desarrolla, manufactura y comercializa productos que ahorran y mantienen las vidas de personas con hemofilia, desórdenes del sistema inmunológico, cáncer, enfermedades infecciosas, enfermedad renal, trauma y otras condiciones médicas crónicas y agudas.  Aprovechando su calidad de compañía de cuidado de la salud diversificada y global, Baxter aplica una combinación única de conocimiento especializado en dispositivos médicos, farmacéutica y biotecnología para crear productos que significan un progreso en el cuidado de los pacientes en todo el mundo.

Acerca de Daiichi Sankyo

El Grupo Daiichi Sankyo se dedica a la creación y provisión de productos farmacéuticos innovadores para abordar las necesidades médicas diversas y no atendidas de pacientes en mercados maduros y mercados emergentes.  Mientras conserva su cartera de productos farmacéuticos en el comercio para hipertensión, hiperlipidemia e infecciones bacterianas, el Grupo participa en el desarrollo de tratamientos para desórdenes trombóticos y se enfoca en el descubrimiento de nóveles terapias cardiovasculares-metabólicas y para oncología. Además, el Grupo Daiichi Sankyo ha creado un "Modelo de Negocios Híbrido" que responderá a la diversidad de mercados y clientes junto con optimizar oportunidades de crecimiento a través de la cadena de valor.  Para más información, por favor visite www.daiichisankyo.com.

Contacto con Coherus Biosciences
George Montgomery
+1-(650)-
'/>"/>

SOURCE Coherus BioSciences
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Coherus Announces CHS-0214 (Proposed Etanercept Biosimilar) Meets Primary Endpoint In Pivotal Pharmacokinetic Clinical Study
2. L.S.E. (Barcelona) anuncia la primera financiación del antiplaquetario NmC por inversores españoles y suizos
3. RPS anuncia a Jonathan M. Fishbein, MD, como vicepresidente ejecutivo y jefe médico
4. RPS anuncia Jonathan M. Fishbein, MD como vice-presidente executivo e diretor médico
5. GenScript Anuncia Exposição Itinerante Junto com a Open Monoclonal Technology, Inc.
6. GenScript anuncia una muestra itinerante conjunta con Open Monoclonal Technology, Inc.
7. GenScript anuncia un programa conjunto con Open Monoclonal Technology, Inc.
8. Novo progresso anunciado na ação judicial contra a Assembleia do Prêmio Nobel movida pelo Dr. Rongxiang Xu
9. Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva
10. Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2
11. ReSearch Pharmaceutical Services anuncia a Marc Wolff como responsable financiero
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... , Sept. 22, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: ... and fiscal 2014 ended July 31, 2014 on Monday, September ... to discuss the results at 11:00 AM ET. Participating in ... Andrew A. Krakauer , President and CEO; Jorgen ... A. Sheldon , Senior Vice President, CFO and Treasurer; and ...
(Date:9/22/2014)... , Sept. 22, 2014  Inovio Pharmaceuticals, Inc. ... has initiated a phase I clinical trial in ... the safety, tolerability, and immunogenicity of INO-3106. This ... causes most aerodigestive cancers. Aerodigestive cancers ... cords, and parts of the esophagus and windpipe. ...
(Date:9/22/2014)... , Sept. 22, 2014  Seres Health, a clinical-stage ... the human microbiome, today announced that it has been ... Fierce 15 biotechnology companies, designating it as one of ... "Amid a great deal of ain,t-it-cool ... focus and commitment to practical therapeutic development," says ...
Breaking Medicine Technology:Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Fourth Quarter And Fiscal 2014 Ended July 31, 2014 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 3Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 4Seres Health Named a "Fierce 15" Biotech Company for 2014 2
... Jan. 4, 2012 /PRNewswire/ -- CryoLife, Inc. (NYSE: ... company focused on cardiac and vascular surgery, announced today ... the position of Vice President, Research and Development; and ... Vice President, Market Development Surgical Adhesives and Starch Medical ...
... /PRNewswire-Asia/ -- The 2011 Medical Korea Awards ceremony was ... the awards ceremony, 10 outstanding medical tourism service providers ... medical tourism agencies, designated as ,first movers, in the ... Yonsei Severance Hospital (General Director: Park Yong-won) won this ...
Cached Medicine Technology:CryoLife Enhances Management Team with Promotions 2CryoLife Enhances Management Team with Promotions 3CryoLife Enhances Management Team with Promotions 4CryoLife Enhances Management Team with Promotions 5Medical Korea Offers 2011 Awards to Top Medical Tourism Service Providers (Institutions) 2
(Date:9/22/2014)... Oaks, CA (PRWEB) September 22, 2014 ... now offering a special offer for Invisalign. Invisalign is ... smiles and correct bite problems. Typical pricing can vary ... and the number of aligners that are needed. During ... for just $4,495. , About a fifth of the ...
(Date:9/22/2014)... The invitation only Summit held on ... industry executives and thought leaders from major fitness ... Fitness, and Xsport Fitness. Also in attendance were ... agencies and private equity investors representing over 1,500 ... The Summit highlighted best practices for solving new ...
(Date:9/22/2014)... -- New research raises doubts about the possible benefits ... cancer who used e-cigarettes along with traditional cigarettes were ... the devices, a Memorial Sloan Kettering study found. These ... likely -- to have quit smoking than patients who ... Sept. 22 in Cancer , involved almost 1,100 ...
(Date:9/22/2014)... 2014 At the 10th Clinton ... Nutrition Partnership (SNP) announced the successful launch of ... Cardiovascular Risk Reduction Program for Women. The announcement ... mitigate their risk of heart disease through a ... plan for addressing significant global challenges made by ...
(Date:9/22/2014)... NY (PRWEB) September 22, 2014 Tristar ... American icon Jack LaLanne, best known as the 'Godfather ... "ANYTHING IS POSSIBLE" premiering September 24th at the ... documentary gives an inspiring insight behind the man whose ... benefits of fitness and nutrition. The name of the ...
Breaking Medicine News(10 mins):Health News:Thousand Oaks Cosmetic Dentist, Sharon Shamoiel DDS, Is Now Offering a Special on Invisalign 2Health News:Motionsoft Concludes Inaugural 2014 Technology Summit 2Health News:Motionsoft Concludes Inaugural 2014 Technology Summit 3Health News:E-Cigarettes Don't Help Cancer Patients Quit Smoking: Study 2Health News:At 2014 Clinton Global Initiative Annual Meeting, Seafood Nutrition Partnership Announces Pilot Program to Reduce Women’s Heart Disease Risks 2Health News:At 2014 Clinton Global Initiative Annual Meeting, Seafood Nutrition Partnership Announces Pilot Program to Reduce Women’s Heart Disease Risks 3Health News:At 2014 Clinton Global Initiative Annual Meeting, Seafood Nutrition Partnership Announces Pilot Program to Reduce Women’s Heart Disease Risks 4Health News:Tristar Products Premieres The Jack LaLanne Documentary at TriBeCa Film Center in New York City 2Health News:Tristar Products Premieres The Jack LaLanne Documentary at TriBeCa Film Center in New York City 3
... to directly measure the brain,s temperature without inserting a probe ... get the brain,s precise temperature with a device the diameter ... to findings presented May 1 at the annual meeting of ... first time that anyone has presented data on the brain ...
... Johns Hopkins have shown in laboratory experiments in mice ... inside the heart,s muscle cells blunts the most serious ... These include heart muscle enlargement, scar tissue formation ... Specifically, the Johns Hopkins team found that their intervention ...
... -- Children born to women exposed to bisphenol A (BPA) ... to experience wheezing early in life, according to a new ... many hard plastic food containers, water bottles and the lining ... in more than 90 percent of the U.S. population, the ...
... News) -- A new study finds that different patterns of ... arterial stiffness, which is associated with cardiovascular disease. Stiff ... and are also associated with a buildup of plaque in ... to a heart attack. In this study, Dr. Danny ...
... reserve" in early-onset Alzheimer,s disease (AD) and PET-CT examinations ... patients. "Although early-onset Alzheimer,s dementia is quite ... carry the diagnosis," said Dr. Jacob Richard Hodge, lead ... Rochester, Minn. "Symptoms are often unexpected and support networks ...
... have discovered a link between low levels of vitamin D ... May 1 at the annual meeting of the Pediatric Academic ... play an important role in anemia. Anemia, which occurs ... is diagnosed and tracked by measuring hemoglobin levels. Symptoms of ...
Cached Medicine News:Health News:Researchers develop device to measures brain temperature non-invasively 2Health News:Animal studies reveal new route to treating heart disease 2Health News:Animal studies reveal new route to treating heart disease 3Health News:Mom's Exposure to Plastics Chemical Tied to Baby's Wheeze 2Health News:PET-CT exams help identify cognitive reserve in early-onset Alzheimer's disease 2Health News:Low vitamin D in kids may play a role in anemia 2
A simple solution to hand assisted laparoscopic surgery....
GelPort hand access laparoscopy combines the patient outcomes of minimally invasive surgery with the speed and precision of open surgery....
... HandPort Systems non-adhesive sealing method ... Laparoscopic Surgrery (HALS) procedures, allowing ... and palpate throughout. Because HALS ... 6 cm, patients experience less ...
The CPAP TREND 110 delivers performance with quiet operation. Can be used together with the SomnoPlus CPAP Mask and AquaTrend Heated Humidifier....
Medicine Products: